CANF · Categories · Form 4

CANF - SEC Form 4 insider transactions

Can-Fite Biopharma Ltd (CANF) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for CANF

• 15h
  SEC Form 4 filed by CEO, CFO and COO Farbstein Motti

  4 - Can-Fite BioPharma Ltd. (0001536196) (Issuer)
• 15h
  SEC Form 4 filed by Chief Scientific Officer Fishman Pnina

  4 - Can-Fite BioPharma Ltd. (0001536196) (Issuer)

Other CANF categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends